Skip to main content

Specialty Pharmacy Medical Step Therapy for Hyaluronan injections (Healthy Blue + Medicare (HMO D-SNP))

Please note, this communication applies to Healthy Blue + Medicare (HMO D-SNP) offered by Blue Cross and Blue Shield of North Carolina.

The following Part B medications from the current Clinical Criteria Guidelines are included in our medical step therapy precertification review process. Step therapy review will apply upon precertification initiation, in addition to the current medical necessity review (as is current procedure). Step therapy will not apply for members who are actively receiving medications listed below.

There are no clinical changes to Clinical Criteria CC-005, Hyaluronan Injections. Based on feedback, the table listing the preferred and non-preferred products has been updated to present the information in a more useful manner. The updated table identifies preferred alternatives based on injection series.

Clinical Criteria Guidelines are publicly available on the provider website. Visit the Clinical Criteria page to search for specific criteria. 

 

Clinical UM GuidelinesPreferred Drug(s)Nonpreferred Drug(s)
CC-0005

Single injection:

  • Durolane

Three injection series:

  • Euflexxa
  • Gel-Syn

Five injection series:

  • Supartz

Single injection:

  • Gel-One
  • Monovisc
  • Synvisc-one

Two injection series:

  • Hymovis

Three injection series:

  • Orthovisc
  • Synojoynt
  • Synvisc
  • Triluron
  • Trivisc

Five injection series:

  • Genvisc 850
  • Hyalgan
  • Visco-3

For more information, please visit Healthy Blue + Medicare.

 

NCBCBS-CR-031135-23-CPN30365 August 2023